Sensitization in transplantation: Assessment of Risk 2022 Working Group Meeting Report.

Autor:	Tambur AR; Department of Surgery, Comprehensive Transplant Center, Northwestern University, Chicago, Illinois, USA. Electronic address: a-tambur@northwestern.edu., Bestard O; Vall d'Hebron Institut de Recerca, Vall d'Hebron Hospital Universitari, Barcelona, Spain., Campbell P; Department of Laboratory Medicine & Pathology, University of Alberta, Edmonton, Canada., Chong AS; Section of Transplantation, Department of Surgery, The University of Chicago, Chicago, Illinois, USA., Barrio MC; Department of Nephrology, Hospital del Mar & Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., Ford ML; Department of Surgery and Emory Transplant Center, Emory University, Atlanta, Georgia, USA., Gebel HM; Department of Pathology, Emory University School of Medicine, Atlanta, Georgia, USA., Heidt S; Department of Immunology, Leiden University Medical Center, Netherlands., Hickey M; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, California, USA., Jackson A; Department of Immunology, Duke University School of Medicine, Durham, North Carolina, USA., Kosmoliaptsis V; Department of Surgery, University of Cambridge, Cambridge, UK., Lefaucheur C; Paris Translational Research Center for Organ Transplantation, Institut national de la santé et de la recherche médicale UMR-S970, Université de Paris, Paris, France., Louis K; Paris Translational Research Center for Organ Transplantation, Institut national de la santé et de la recherche médicale UMR-S970, Université de Paris, Paris, France., Mannon RB; Department of Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA., Mengel M; Department of Laboratory Medicine & Pathology, University of Alberta, Edmonton, Canada., Morris A; Department of Pathology, Emory University School of Medicine, Atlanta, Georgia, USA., Pinelli DF; Department of Surgery, Comprehensive Transplant Center, Northwestern University, Chicago, Illinois, USA., Reed EF; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, California, USA., Schinstock C; Department of Medicine, Mayo Clinical, Rochester, Minnesota, USA., Taupin JL; Department of Immunology, Saint Louis Hospital and University Paris-Cité, Paris, France., Valenzuela N; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, California, USA., Wiebe C; Department of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada., Nickerson P; Department of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
Jazyk:	angličtina
Zdroj:	American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons [Am J Transplant] 2023 Jan; Vol. 23 (1), pp. 133-149. Date of Electronic Publication: 2023 Jan 11.
DOI:	10.1016/j.ajt.2022.11.009
Abstrakt:	The Sensitization in Transplantation: Assessment of Risk workgroup is a collaborative effort of the American Society of Transplantation and the American Society of Histocompatibility and Immunogenetics that aims at providing recommendations for clinical testing, highlights gaps in current knowledge, and proposes areas for further research to enhance histocompatibility testing in support of solid organ transplantation. This report provides updates on topics discussed by the previous Sensitization in Transplantation: Assessment of Risk working groups and introduces 2 areas of exploration: non-human leukocyte antigen antibodies and utilization of human leukocyte antigen antibody testing measurement to evaluate the efficacy of antibody-removal therapies. (Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu